Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.22.2.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Research and development $ 1,223,776 $ 715,098
General and administrative 1,388,271 839,826
Total operating expenses 2,612,047 1,554,924
Loss from operations (2,612,047) (1,554,924)
Other income, net 212 1,529
Net loss $ (2,611,835) $ (1,553,395)
Weighted average common shares outstanding, basic and diluted 23,416,495 23,344,567
Net loss per share, basic and diluted $ (0.11) $ (0.07)